TARA
Price:
$5.17
Market Cap:
$177.43M
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.[Read more]
Industry
Biotechnology
IPO Date
2014-10-22
Stock Exchange
NASDAQ
Ticker
TARA
According to Protara Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.96. This represents a change of 113.93% compared to the average of -0.92 of the last 4 quarters.
The mean historical PE Ratio of Protara Therapeutics, Inc. over the last ten years is -4.07. The current -1.96 PE Ratio has changed 4.71% with respect to the historical average. Over the past ten years (40 quarters), TARA's PE Ratio was at its highest in in the December 2019 quarter at 8.82. The PE Ratio was at its lowest in in the December 2018 quarter at -195.71.
Average
-4.07
Median
-1.36
Minimum
-11.95
Maximum
-0.07
Discovering the peaks and valleys of Protara Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 7.18%
Maximum Annual PE Ratio = -0.07
Minimum Annual Increase = -99.22%
Minimum Annual PE Ratio = -11.95
Year | PE Ratio | Change |
---|---|---|
2023 | -0.53 | 13.20% |
2022 | -0.47 | -71.06% |
2021 | -1.61 | -69.22% |
2020 | -5.23 | 7.18% |
2019 | -0.07 | -99.22% |
2018 | -9.14 | 734.41% |
2017 | -1.10 | -0.70% |
2016 | -1.10 | -90.77% |
2015 | -11.95 | 25.27% |
2014 | -9.54 | -49.83% |
The current PE Ratio of Protara Therapeutics, Inc. (TARA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.87
5-year avg
-1.58
10-year avg
-4.07
Protara Therapeutics, Inc.’s PE Ratio is less than Vaccinex, Inc. (-0.13), less than Monopar Therapeutics Inc. (-0.59), greater than Miromatrix Medical Inc. (-7.13), less than Surrozen, Inc. (-0.89), less than Ikena Oncology, Inc. (0), less than Xilio Therapeutics, Inc. (-1.24), less than Scholar Rock Holding Corporation (-1.16), greater than Vaccitech plc (-19.57), less than Metacrine, Inc. (-0.75), less than Magenta Therapeutics, Inc. (-0.40), less than TRACON Pharmaceuticals, Inc. (-0.15), less than Satsuma Pharmaceuticals, Inc. (0.02), less than Lyra Therapeutics, Inc. (-0.51), less than Trevi Therapeutics, Inc. (-0.12), greater than SQZ Biotechnologies Company (-9.12), less than null (-0.02),
Company | PE Ratio | Market cap |
---|---|---|
-0.13 | $3.16M | |
-0.59 | $116.38M | |
-7.13 | $92.95M | |
-0.89 | $39.78M | |
0 | $73.83M | |
-1.24 | $50.55M | |
-1.16 | $4.27B | |
-19.57 | $192.73M | |
-0.75 | $0 | |
-0.40 | $42.44M | |
-0.15 | $109.72K | |
0.02 | $36.47M | |
-0.51 | $11.28M | |
-0.12 | $357.46M | |
-9.12 | $12.83M | |
-0.02 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Protara Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Protara Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Protara Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Protara Therapeutics, Inc. (TARA)?
What is the highest PE Ratio for Protara Therapeutics, Inc. (TARA)?
What is the 3-year average PE Ratio for Protara Therapeutics, Inc. (TARA)?
What is the 5-year average PE Ratio for Protara Therapeutics, Inc. (TARA)?
How does the current PE Ratio for Protara Therapeutics, Inc. (TARA) compare to its historical average?